Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TET2 | Q6N021 | 5/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TET3 | O43151 | 1/20 | 0.31 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.31 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.30 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.30 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.30 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL161220 | 0.98 | TET2 (0.36) | TET2ALOX15HSD17B10TET3TET1 | |
| Bromide SCHEMBL8931105 | 0.98 | TET2 (0.36) | TET2ALOX15HSD17B10TET3TET1 | |
| Sulfuric Acid SCHEMBL9103493 | 0.92 | TET2 (0.33) | TET2ALOX15HSD17B10 | |
| SCHEMBL4654955 | 0.88 | TET2 (0.35) | TET2ALOX15HSD17B10 | |
| SCHEMBL1770041 | 0.86 | TET2 (0.30) | TET2 | |
| Hydrochloric Acid SCHEMBL4387248 | 0.86 | TET2 (0.34) | TET2ALOX15HSD17B10 | |
| SCHEMBL7856854 | 0.85 | LMNA (0.40) | ALOX15 | |
| SCHEMBL1006556 | 0.79 | TET2 (0.35) | TET2ALOX15HSD17B10 | |
| Hydrochloric Acid SCHEMBL7764314 | 0.78 | TET2 (0.34) | TET2ALOX15HSD17B10 | |
| SCHEMBL1018910 | 0.77 | TET2 (0.50) | TET2ALOX15HSD17B10TET3TET1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 221 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3788125-B1 | DISHWASHING DETERGENT FORMULATIONS COMPRISING POLYASPARTIC ACID AND GRAFT POLYMERS BASED ON OLIGO- AND POLYSACCHARIDES AS FILM INHIBITING ADDITIVES | BASF SE (DE) | 2024-03-13 | — | — | EP | claimed |
| EP-4294559-A1 | POROUS SORPTIVE SOLID PHASE MICROEXTRACTION DEVICES AND PREPARATION THEREOF | Memorial University of Newfoundland (CA) | 2023-12-27 | — | — | EP | claimed |
| WO-2018137686-A9 | DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES | Triastek, Inc. (CN) | 2018-12-27 | — | — | WO | claimed |
| WO-2018137686-A1 | DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES | Triastek, Inc. (CN) | 2018-08-02 | — | — | WO | claimed |
| EP-2086519-B1 | CONTROLLED RELEASE COMPLEX COMPOSITION COMPRISING ANGIOTENSIN-II-RECEPTOR BLOCKERS AND HMG-COA REDUCTASE INHIBITORS | HANALL BIOPHARMA CO LTD (KR) | 2017-06-21 | — | — | EP | claimed |
| US-9303096-B2 | Expandable elastomeric material in the presence of water or oil | RHODIA OPERATIONS (FR) | 2016-04-05 | — | — | US | claimed |
| US-8642083-B2 | Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitors | HANALL BIOPHARMA CO., LTD. (KR) | 2014-02-04 | — | — | US | claimed |
| EP-2373774-B1 | IMPROVEMENTS RELATING TO FABRIC CONDITIONERS | UNILEVER PLC (GB) | 2013-03-20 | — | — | EP | claimed |
| EP-1173878-B1 | PROBES FOR A GAS PHASE ION SPECTROMETER | BIO RAD LABORATORIES (US) | 2011-04-06 | — | — | EP | claimed |
| EP-1909741-B1 | denture support composition | RECKITT BENCKISER UK LTD (GB) | 2010-11-10 | — | — | EP | claimed |
| WO-2007145991-A2 | ANTI-INFLAMMATORY AND ANALGESIC COMPOSITIONS AND RELATED METHODS | LIPOCINE, INC. (US) | 2007-12-21 | — | — | WO | claimed |
| US-20070281927-A1 | Anti-inflammatory and analgesic compositions and related methods | LIPOCINE, INC. | 2007-12-06 | — | — | US | claimed |
| US-20070275061-A1 | PHARMACEUTICAL COMPOSITIONS AND FORMULATIONS OF METFORMIN EXTENDED RELEASE TABLETS | HANALL PHARMACEUTICAL CO., LTD. (KR) | 2007-11-29 | — | — | US | claimed |
| WO-2005123138-A9 | PHARMACEUTICAL PELLET COMPOSITIONS FOR CONTROLLED RELEASE | CHONG KUN DANG PHARM CORP (KR) | 2006-04-06 | — | — | WO | claimed |
| WO-2005123138-A1 | PHARMACEUTICAL PELLET COMPOSITIONS FOR CONTROLLED RELEASE | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2005-12-29 | — | — | WO | claimed |
| EP-0923611-B1 | POLYACRYLAMIDE POLYMERISATION | ICI PLC (GB) | 2004-01-28 | — | — | EP | claimed |
| WO-2001006011-A2 | ARRAYS COMPRISING NON-COVALENTLY ASSOCIATED NUCLEIC ACID PROBES AND METHODS FOR MAKING AND USING THEM | GENOMETRIX GENOMICS, INC. (US) | 2001-01-25 | — | — | WO | claimed |
| EP-0646038-B1 | PASSIVATED AND STABILIZED POROUS SUPPORTS AND METHODS FOR THE PREPARATION AND USE OF SAME | LIFE TECHNOLOGIES INC (US) | 2000-11-15 | — | — | EP | claimed |
| EP-0580529-B1 | Process for making paper or cardboard having improved retention | S N F (FR) | 1996-04-17 | — | — | EP | claimed |
| EP-0580529-A1 | Process for making paper or cardboard having improved retention | S. N. F. (FR) | 1994-01-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281927-A1 | Anti-inflammatory and analgesic compositions and related methods | MB, PTGS1, PTGS2 | TET2 2495/4885ALOX15 19/4885HSD17B10 2775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.